Cargando…

Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients

Osteoporosis is a common systemic bone disease caused by the imbalance between osteogenic activity and osteoclastic activity. Aged women are at higher risk of osteoporosis, partly because of estrogen deficiency. However, the underlying mechanism of how estrogen deficiency affects osteoclast activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yi-Xuan, He, Wen-Ge, Cai, Hai-Jun, Jiang, Jin-Hai, Yang, Yuan-Yuan, Dan, Yan-Rong, Luo, Hong-Hong, Du, Yu, Chen, Liang, He, Bai-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792966/ https://www.ncbi.nlm.nih.gov/pubmed/35095774 http://dx.doi.org/10.3389/fendo.2021.815245

Ejemplares similares

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: A retrospective study in Chinese population
por: Li, Hailin, et al.
Publicado: (2023)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
por: Hu, Yunxiang, et al.
Publicado: (2022)

Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
por: Kou, Jun, et al.
Publicado: (2022)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Integrative Analyses of Genes Associated With Osteoporosis in CD16+ Monocyte
por: Hu, Bin, et al.
Publicado: (2021)

Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
por: Wawrzyniak, Anna, et al.
Publicado: (2023)

Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer’s Disease
por: Xu, Yunteng, et al.
Publicado: (2022)

Identification of hub genes associated with postmenopausal osteoporosis by Gibbs sampling method
por: Zhang, Ya-Peng, et al.
Publicado: (2019)

Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis
por: Luo, Ming-hui, et al.
Publicado: (2022)

Low BMI, blood calcium and vitamin D, kyphosis time, and outdoor activity time are independent risk factors for osteoporosis in postmenopausal women
por: Tang, Guo, et al.
Publicado: (2023)

Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells
por: Dong, Qianqian, et al.
Publicado: (2022)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women
por: Marozik, Pavel M., et al.
Publicado: (2018)

Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis: An overview of systematic reviews of randomized controlled trials
por: Zhao, Jinlong, et al.
Publicado: (2022)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Hub genes and gene functions associated with postmenopausal osteoporosis predicted by an integrated method
por: Cao, Honghai, et al.
Publicado: (2019)

Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
por: Bülow, Jasmin Maria, et al.
Publicado: (2022)

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Impact of Osteoporosis in Postmenopausal Women With Primary Knee Osteoarthritis
por: Zamzam, Mohammed, et al.
Publicado: (2023)

Recurrent Implantation Failure May Be Identified by a Combination of Diagnostic Biomarkers: An Analysis of Peripheral Blood Lymphocyte Subsets
por: Cai, Jun-Ying, et al.
Publicado: (2022)

Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis
por: Wang, Xiaoning, et al.
Publicado: (2022)

Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
por: Zhao, Jinqiu, et al.
Publicado: (2021)

Mitochondrial quality control and its role in osteoporosis
por: Yan, Chunlu, et al.
Publicado: (2023)

Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis
por: Li, Yuan, et al.
Publicado: (2022)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
por: Yang, Yi‐ran, et al.
Publicado: (2019)

Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-Analysis
por: Gu, Hai-Feng, et al.
Publicado: (2015)

Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis
por: Yuan, Wei, et al.
Publicado: (2022)

Integration of Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanisms of Zhuanggu Busui Formula Against Osteoporosis
por: Zhang, Huihao, et al.
Publicado: (2022)

Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis
por: Liu, Huilan, et al.
Publicado: (2022)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis
por: Zhou, Siming, et al.
Publicado: (2019)

Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis
por: Fei, Qi, et al.
Publicado: (2018)

Application of metabolomics in osteoporosis research
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Validation of an osteoporosis self-assessment tool to identify primary osteoporosis and new osteoporotic vertebral fractures in postmenopausal Chinese women in Beijing
por: Yang, Yong, et al.
Publicado: (2013)

Common variants in MAEA gene contributed the susceptibility to osteoporosis in Han Chinese postmenopausal women
por: Cai, Xuan, et al.
Publicado: (2021)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
por: Dai, Zhijie, et al.
Publicado: (2023)

Comparison of four tools to identify painful new osteoporotic vertebral fractures in the postmenopausal population in Beijing
por: Guo, SiJia, et al.
Publicado: (2022)

Effect of Body Surface Area on Severe Osteoporotic Fractures: A Study of Osteoporosis in Changsha China
por: Wu, Xi-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qu81fu8q56unre43de113do7or